StockData
Clearmind Medicine Inc. logo

Clearmind Medicine Inc. (CMND) stock

CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.45−0.73 (-17.52%)

Close on Nov 17, 2026Market cap $545.36KP/E –Yield –

Clearmind Medicine operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Clearmind Medicine's operating cash flow for the twelve months ending Jul 31, 2026 was -$7.07M. For fiscal 2025 it was -$4.73M. The highest annual figure on record is -$2.08M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Oct 31, 2025-$4.73M–
FY2024Oct 31, 2024-$4.86M–
FY2023Oct 31, 2023-$6.30M–
FY2022Oct 31, 2022-$3.72M–
FY2021Oct 31, 2021-$2.08M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jul 31, 2026-$1.93M–
Q2 FY2026CQ1 2026Apr 30, 2026-$1.77M–
Q1 FY2026CQ4 2025Jan 31, 2026-$2.08M–
Q4 FY2025CQ3 2025Oct 31, 2025-$1.29M–
Q3 FY2025CQ2 2025Jul 31, 2025-$1.08M–
Q2 FY2025CQ1 2025Apr 30, 2025-$1.10M–
Q1 FY2025CQ4 2024Jan 31, 2025-$1.27M–
Q4 FY2024CQ3 2024Oct 31, 2024-$1.08M–
Q3 FY2024CQ2 2024Jul 31, 2024-$1.13M–
Q2 FY2024CQ1 2024Apr 30, 2024-$1.19M–
Q1 FY2024CQ4 2023Jan 31, 2024-$1.46M–
Q4 FY2023CQ3 2023Oct 31, 2023-$753.17K–
Q3 FY2023CQ2 2023Jul 31, 2023-$1.38M–
Q2 FY2023CQ1 2023Apr 30, 2023-$1.07M–
Q1 FY2023CQ4 2022Jan 31, 2023-$3.10M–

More Clearmind Medicine figures

See a number that looks wrong?